Jeannette Potts

Autre

Forma Therapeutics Holdings, Inc.uniQure N.V.uniQure N.V.

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 1 saleJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 1 saleApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (6 ops.)

€292k

Latest filing published 06 Mar 2026 for uniQure N.V..

Filing timeline

BuySale

Jeannette Potts

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Jeannette Potts: trading record in brief

This profile gathers the share dealings of Jeannette Potts across 2 companies, led by uniQure N.V. and Forma Therapeutics Holdings, Inc. We count 16 filings; the first trade dates from 30 December 2020 and the latest from 4 March 2026.

On the market, this insider has only sold: 6 sales, €292k in total. Besides market trades, the filings include 7 share grants and 1 option exercise. Since January 2026: no purchases and 2 sales on the market.

Most recently, on 6 March 2026, the filings show an open-market sale worth €27k in uniQure N.V. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.